Clinical Scorecard: Mastering Myopia: Innovations and Future Directions
At a Glance
| Category | Detail |
|---|---|
| Condition | Myopia |
| Key Mechanisms | Combination therapies, specialty lenses, and emerging technologies. |
| Target Population | Children and adolescents with myopia. |
| Care Setting | Optometry and ophthalmology clinics. |
Key Highlights
- Ortho-k and multifocal soft lenses effectively slow myopia progression.
- Combination therapy with atropine and specialty lenses is gaining traction.
- Emerging technologies include smart contact lenses and light-based therapies.
Guideline-Based Recommendations
Diagnosis
- Assess myopia severity and progression in children and adolescents.
Management
- Consider ortho-k, multifocal lenses, and atropine for myopia control.
Monitoring & Follow-up
- Utilize wearable devices to track visual habits and compliance.
Risks
- Monitor for potential rebound effects with atropine therapy.
Patient & Prescribing Data
Children and adolescents with progressive myopia.
Higher concentrations of atropine may enhance myopia control.
Clinical Best Practices
- Integrate combination therapies for individualized treatment plans.
- Stay updated on emerging technologies and their applications in myopia management.
References
- Wildsoet et al, 2019
- Zhang et al, 2024
- Tsai et al, 2022
- Liu et al, 2024
- Xu et al, 2024
- Zhang and Zou, 2024
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.